HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of prolyl hydroxylase-2 for stabilization of mitochondrial stress along with simultaneous downregulation of HIF-1α/FASN in ER + breast cancer subtype.

Abstract
The present study was undertaken to inquest the chemical activation of prolyl hydroxylase-2 for the curtailment of hypoxia-inducible factor-1α and fatty acid synthase. It was well documented that hypoxia-inducible factor-1α and fatty acid synthase were overexpressed in mammary gland carcinomas. After screening a battery of compounds, BBAP-2 was retrieved as a potential prolyl hydroxylase-2 activator and validates its activity using ER + MCF-7 cell line and n-methyl-n-nitrosourea-induced rat in vivo model, respectively. BBAP-2 was palpable for the morphological characteristics of apoptosis along with changes in the mitochondrial intergrity as visualized by acridine orange/ethidium bromide and JC-1 staining against ER + MCF-7 cells. BBAP-2 also arrest the cell cycle of ER + MCF-7 cells at G2/M phase. Afterward, BBAP-2 has scrutinized against n-methyl-n-nitrosourea-induced mammary gland carcinoma in albino Wistar rats. BBAP-2 restored the morphological architecture when screened through carmine staining, haematoxylin and eosin staining, and scanning electron microscopy. BBAP-2 also delineated the markers of oxidative stress favourably. The immunoblotting and mRNA expression analysis validated that BBAP-2 has a potentialty activate the prolyl hydroxylase-2 with sequential downregulating effect on hypoxia-inducible factor-1α and its downstream checkpoint. BBAP-2 also fostered apoptosis through mitochondrial-mediated death pathway. The present study elaborates the chemical activation of prolyl hydroxylase-2 by which the increased expression of HIF-1α and FASN can be reduced in mammary gland carcinoma.
AuthorsUma Devi, Manjari Singh, Subhadeep Roy, Pushpraj S Gupta, Mohd Nazam Ansari, Abdulaziz S Saeedan, Gaurav Kaithwas
JournalCell biochemistry and function (Cell Biochem Funct) Vol. 37 Issue 4 Pg. 216-227 (Jun 2019) ISSN: 1099-0844 [Electronic] England
PMID30950543 (Publication Type: Journal Article)
Copyright© 2019 John Wiley & Sons, Ltd.
Chemical References
  • Antineoplastic Agents
  • Benzopyrans
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Receptors, Estrogen
  • EGLN1 protein, human
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • FASN protein, human
  • Fatty Acid Synthase, Type I
Topics
  • Animals
  • Antineoplastic Agents (chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Benzopyrans (chemistry, pharmacology)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Cell Proliferation (drug effects)
  • Down-Regulation (drug effects)
  • Drug Screening Assays, Antitumor
  • Enzyme Activation (drug effects)
  • Fatty Acid Synthase, Type I (metabolism)
  • Female
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Hypoxia-Inducible Factor-Proline Dioxygenases (metabolism)
  • MCF-7 Cells
  • Mammary Neoplasms, Experimental (drug therapy, metabolism, pathology)
  • Mitochondria (drug effects, metabolism, pathology)
  • Rats
  • Rats, Wistar
  • Receptors, Estrogen (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: